ELV

$291.48+0.33 (+0.11%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$291.48
Potential Upside
76.8%
Whystock Fair Value$515.37
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealthcare Plans

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of heal...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$64.33B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.56
Beta
Defensive asset. Lower volatility than the S&P 500.
0.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
12.21%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
-

Recent News

Simply Wall St.
Mar 18, 2026

A Look At Elevance Health’s (ELV) Valuation After Recent Share Price Volatility

Elevance Health (ELV) is back in focus after recent share price moves, with the stock showing gains over the past week but declines over the month and past 3 months catching investor attention. See our latest analysis for Elevance Health. Zooming out, Elevance Health shows short term momentum building, with a 1 week share price return of 4.62%. This comes against a weaker backdrop that includes a 30 day share price return decline of 14.72% and a 1 year total shareholder return decline of...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

UNH Expands Doulas: Better Outcomes or Margin Play Ahead?

UnitedHealth Group rolls out nationwide doula coverage, targeting better maternal outcomes and lower costs through preventive, value-based care.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 17, 2026

Mizuho Lowers PT on Elevance Health (ELV), Keeps a Buy Rating

Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Mizuho analyst Ann Hynes lowered the firm’s price target on Elevance Health, Inc. (NYSE:ELV) from $413 to $350 and maintained a Buy rating on the stock. ​The analyst noted that the reduced price target […]

BEARISH
Negative press. News cycle fixated on risk factors or misses.
StockStory
Mar 13, 2026

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 3.8% over the past six months, almost identical to the S&P 500.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 12, 2026

Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative

Elevance Health (NYSE:ELV) entered into new network participation agreements with Myomo. The agreements expand coverage for advanced orthotic devices to tens of millions of Elevance members. Coverage spans commercial, Medicare Advantage, and Medicaid plans, adding to Elevance's technology-enabled care offerings. For you as an investor, this move speaks directly to how Elevance Health is shaping its core health benefits business around technology-enabled, patient-centered care. The Myomo...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.